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Abstract
Deoxyribosyl transferases and functionally related purine nucleoside
phosphorylases are used extensively for synthesis of non-natural
deoxynucleosides as pharmaceuticals or standards for characterizing and
quantitating DNA adducts. Hence exploring the conformational tolerance of the
active sites of these enzymes is of considerable practical interest. We have
determined the crystal structure at 2.1 Å resolution of Lactobacillus helveticus
purine deoxyribosyl transferase (PDT) with the tricyclic purine 8,9-dihydro-9-
oxoimidazo[2,1-b]purine (N2,3-ethenoguanine) at the active site. The active site
electron density map was compatible with four orientations, two consistent with
sites for deoxyribosylation and two appearing to be unproductive. In accord with the
crystal structure, Lactobacillus helveticus PDT glycosylates the 8,9-dihydro-9-
oxoimidazo[2,1-b]purine at N7 and N1, with a marked preference for N7. The
activity of Lactobacillus helveticus PDT was compared with that of the nucleoside
29-deoxyribosyltransferase enzymes (DRT Type II) from Lactobacillus leichmannii
and Lactobacillus fermentum, which were somewhat more effective in the
deoxyribosylation than Lactobacillus helveticus PDT, glycosylating the substrate
with product profiles dependent on the pH of the incubation. The purine nucleoside
phosphorylase of Escherichia coli, also commonly used in ribosylation of non-
natural bases, was an order of magnitude less efficient than the transferase
enzymes. Modeling based on published active-site structures as templates
suggests that in all cases, an active site Phe is critical in orienting the molecular
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plane of the purine derivative. Adventitious hydrogen bonding with additional active
site residues appears to result in presentation of multiple nucleophilic sites on the
periphery of the acceptor base for ribosylation to give a distribution of nucleosides.
Chemical glycosylation of O9-benzylated 8,9-dihydro-9-oxoimidazo[2,1-b]purine
also resulted in N7 and N1 ribosylation. Absent from the enzymatic and chemical
glycosylations is the natural pattern of N3 ribosylation, verified by comparison of
spectroscopic and chromatographic properties with an authentic standard
synthesized by an unambiguous route.
Introduction
Non-natural deoxynucleosides and deoxynucleoside analogs are important as
therapeutic drugs [1–3], as probes for mechanisms of parasite-transmitted disease
[4] and mechanisms of DNA repair [5] and for identifying and characterizing
DNA damage. Chemical synthesis of non-natural nucleosides typically involves
protection/deprotection steps and reaction conditions under which the glycosidic
bond may be labile, resulting in low yields and difficult purification. Enzymic
deoxyribosylation of modified nucleobases or glycosylation with non-natural
sugars can offer an alternative synthetic pathway with high yields and stereo- and
regioselectivity. As a consequence, the synthetic utility of deoxyribosyltransferase
(DRT) and purine nucleoside phosphorylase (PNP) enzymes has been explored.
Two classes of DRT enzymes can be isolated from the Lactobacilli species
Lactobacillus helveticus (L. helveticus) and Lactobacillus leichmanii (L. leichmanii)
[6]. Type I DRT (purine deoxyribosyltransferase; PDT) enzymes transfer
deoxyribose groups exclusively from purine to purine, while Type II DRT
(nucleoside deoxyribosyltransferase; NDT) enzymes can utilize purines and
pyrimidines as both donors and acceptors. Although the PDT and NDT enzymes
show some structural similarity [6], NDT enzymes have been favored as
biocatalysts since they are more flexible than PDT enzymes with regard to the type
of donor base while retaining absolute stereospecificity for generating the b-
deoxyribose anomer [3], thus expanding the pool of available donors and
acceptors for transfer of modified sugars. Escherichia coli (E. coli) PNP in the
presence of uridine or thymidine phosphorylases and the appropriate deoxyribose
donor has also been used for this purpose [1, 2, 7].
To define the range of structures suitable as deoxyribosyl acceptors, a number
of structural studies of DRTs and PNPs have been undertaken [8–10]. Although
deoxyribosyl transfer to purine or pyrimidine acceptors is highly regioselective for
natural substrates, modified bases or base analogs may be deoxyribosylated at
multiple sites [8, 11–14]. L. helveticus PDT transfers 2-deoxyribose to N3, N7 or
N9 of sterically compact guanine derivatives [8], suggested by structural studies to
be a consequence of latitude in substrate orientation within the active site through
alternative hydrogen bonding schemes with active-site residues. Here we
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investigate deoxyribosylation of the angular tricyclic base 8,9-dihydro-9-
oxoimidazo[2,1-b]purine (1; Fig. 1) to determine active site steric constraints of
DRT enzymes with a sterically demanding acceptor.
The tricyclic framework formed by fusion of a 5-membered ring on the
Watson-Crick pairing edge of the nucleobase between the exocyclic N2 and
endocyclic N3 of guanine renders 1 sterically bulkier than guanine analogs
previously investigated by X-ray crystallography. In a study of product
distributions from glycosylation of a series of substrates, a crude PDT preparation
isolated from L. helveticus has been reported to deoxyribosylate 1 at N1 and N3
[14]. We report the structure of 1 complexed at the active site of L. helveticus PDT
and take advantage of available crystal structures of the NDT from L. leichmannii
and of the E. coli PNP to examine more generally the regiochemistry of the
enzymatic glycosylation by modeling 1 at the active sites of these enzymes. We
have generated product profiles from transdeoxyribosylation in vitro by L.
helveticus PDT, the L. leichmannii and Lactobacillus fermentum NDTs, and with E.
coli PNP and discuss the product profiles generated from the enzymatic
deoxyribosylation in terms of the crystal structure and modeling results. For
comparison, we have also determined the deoxyribosylation products obtained
from 1 by a published chemical reaction.
Materials and Methods
Chemicals
Solvents were HPLC grade and were purchased from Fisher Scientific Co. or
Mallinckrodt Baker, Inc., except for ethanol, which was purchased from AAPER
Alcohol and Chemical Co. Ammonium hydroxide, sodium bicarbonate, HCl,
acetic acid, acetic anhydride, and potassium monohydrogen phosphate were
obtained from Fisher Scientific Co. 29-Deoxyguanosine was purchased from USB
Corp. and benzyl alcohol from J. T. Baker. All other reagents were purchased from
Sigma-Aldrich and used as received. Hydrogen gas was purchased from National
Welders Supply Co. 3,5-Di-O-(p-toluyl)-2-deoxy-D-ribofuranosyl chloride was
synthesized according to a published procedure [15], as was O6-benzylguanine
[16]. 8,9-Dihydro-9-oxoimidazo[2,1-b]purine (1) was synthesized [17] and
glycosylated [18, 19] according to published procedures, described in detail, along
with complete characterization, as S1 Materials. By 1H NMR and HPLC analysis,
Fig. 1. Structure and numbering convention of 8,9-dihydro-9-oxoimidazo[2,1-b]purine (1).
doi:10.1371/journal.pone.0115082.g001
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the final product was greater than 95% pure, with 5,9-dihydro-9-oxoimidazo[1,2-
a]purine (2) as an identifiable impurity. 8,9-Dihydro-9-oxo-3-(2-deoxy-b-D-
ribofuranosyl)-imidazo[2,1-b]purine (3) was synthesized as a reference standard
by a published procedure [20], described in detail in S1 Materials, along with
definitive characterization by 2D NMR methods.
Instrumentation
NMR spectra were recorded on a Varian Inova NMR spectrometer equipped with
a cold probe at 500 MHz for acquisition of 1H data and 125 MHz for 13C data.
Low resolution ESI-MS/MS data were acquired on a Finnigan DECA system. High
resolution mass measurements were obtained on a Bruker FT-ICR-MS equipped
with a capillary ESI source by flow injection of 4–6 mL samples, with angiotensin I
(0.02 mg/mL) as the calibration standard. UV-vis spectra were recorded on a Cary
300, with Cary Win UV software. HPLC was carried out on a Thermo LC with an
Altech UV-Vis detector and Ezstar software (EZCHROM).
Chromatography
Both analytical and semi-preparative HPLC separations were carried out on a
reverse phase Eclipse XDB C18 column (15064.6 mm) at a flow rate of 1 mL/
min, as described below. Analytical thin-layer chromatography (TLC) was
performed on silica-coated aluminum plates (particle size 17 mm, 200 mm
thickness) purchased from Sigma-Aldrich, and preparative TLC on silica-coated
glass plates (particle size 40-63 mm, 500 or 1000 mm thickness), purchased from
Analtech Inc.
Enzymes
L. helveticus PDT, L. fermentum NDT [21] and L. leichmannii NDT were purified
as follows. 500 mL of LB medium inoculated with an overnight culture of
BL21(DE3)pLysS containing either pETLH4 (L. helveticus PTD), pETLL7 (L.
leichmannii NDT), or pLF6 (L. fermentum NDT) was grown under agitation at
37 C̊ until A600<0.6. Isopropyl-1-thio-b-D-galacto-pyranoside was added to a
final concentration of 1 mM, and the cultures were incubated for 2.5 h. Bacteria
were centrifuged, washed once with 0.1 M phosphate buffer (pH 7.5). Pellets were
frozen at 220 C̊. Cells were resuspended in 20 mL of phosphate buffer and
broken by one passage through a French press at 14000 p.s.i. The lysate was
centrifuged at 23,0006g for 1 h, and the supernatant was precipitated by addition
of solid ammonium sulfate to 30–40% saturation. Proteins were pelleted by
centrifugation at 8,0006g for 30 min and resuspended in phosphate buffer. Each
protein was further purified by filtration on a Sephacryl S-200 column previously
equilibrated in sodium phosphate buffer containing 0.1 M NaCl (pH 6.0). The
elution was followed by UV absorption at 280 nm, and each fraction was analyzed
by SDS-PAGE electrophoresis and by following the transfer activity using dC+A
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for the NDTs and dG+ A for the PDT. Protein concentrations were measured by
UV absorption. PNP (EC 2.4.2.1) and thymidine phosphorylase (EC 2.4.2.4) from
E. coli were purchased from Sigma-Aldrich and used as received.
PDT Crystallization Conditions
Pure protein was buffer exchanged into 20 mM 2-(N-morpholino)ethanesulfonic
acid (pH 8.0) to a final concentration of 20 mg/mL. Native PDT crystals were
grown at 22 C̊ by the hanging-drop vapor diffusion method over 3–5 days. Drops
containing 1 mL of protein and 1 mL of reservoir solution were found to be
optimal for crystal growth. Diffraction quality crystals were obtained under the
previously-optimized condition of 100 mM Tris (pH 7.9) and 2.2 M ammonium
sulfate [8]. The native crystals were gradually soaked into stabilizing solutions of
mother liquor containing 20–25% PEG 4000 and 1 from 2 mM up to 6 mM. The
crystals were soaked in each solution for approximately one hour and kept
overnight in the final solution at 6 mM 1.
Data Collection and Processing
The PDT-1 complex datasets were collected at NE-CAT 24-ID-E beamline, at the
Advanced Photon Source (Argonne National Laboratory, Argonne, IL) using a
Quantum 315 detector (Area Detector Systems Corp.). Crystals were flash frozen
in liquid nitrogen with 20% glycerol as cryoprotectant. The data were indexed,
integrated and scaled using the HKL2000 program suite [22]. Data collection and
data processing statistics are shown in Table 1.
Model Building and Refinement
PDT crystallizes in the tetragonal space group P43212 with 3 monomers in the
asymmetric unit. The corresponding Matthews coefficient and solvent contents
are 2.53 and 55% respectively [23]. The native PDT structure (PDB ID 1S2L) [8]
was used as a starting model and the model was subsequently refined using rounds
of rigid body refinement, simulated annealing, temperature factor refinement and
minimization. Initial refinement cycles were performed with noncrystallographic
symmetry (NCS) [24] and final rounds with the PHENIX suite of programs [25].
Coot [26] was used for model building. The NCS constraints were kept tight in
the initial rounds of refinement and slowly relaxed in the final round. Water
molecules were added and refined in the final rounds of refinement. The
parameter and topology files for the ligand were generated with the Dundee
PRODRG2 server [27]. The refinement statistics are summarized in Table 2.
Complete structure factor data and final coordinates were deposited in the Protein
Data Bank (www.rcsb.org): PDB ID code 4MEJ.
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Modeling of the active site of L. leichmannii NDT and E. coli PNP
Computational docking studies were based on docking of 1 into the active site
cavities using AutoDock Vina 1.1.1 [28] followed by conformational searching for
optimal orientations from docking to more rigorously explore the active site using
Schrodinger MacroModel 9.9 [29]. For L. leichmannii NDT, PDB structure 1F8Y
[9] with bound 5-methyl-29-deoxypseudouridine (5-Me-dyUrd; 2.4 Å resolu-
tion) was used as a template, and for E. coli PNP, the template was PDB structure













b (%) 4.6 (26.6)
I/s 23.1 (4.8)
aValues for the highest resolution shell are given in parentheses.
bRsym5SSi Ii2,I. |/S,I., where ,I. is the mean intensity of the N reflections with intensities Ii and common indices h,k,l.
doi:10.1371/journal.pone.0115082.t001
Table 2. Final refinement statistics for PDT crystallized with 8,9-dihydro-9-oxoimidazo[2,1-b]purine.
Parameters Values
Resolution (Å) 2.1
Number of protein atoms 3844
Number of water molecules 300
Number of ligand atoms 44
Root mean square deviation from ideal geometry
bonds (Å) 0.004
angles (deg) 0.852




most favored region (%) 86.8
additionally allowed regions (%) 12.5
generously allowed regions (%) 0.2
disallowed regions (%) 0.5
aR factor 5Shkl||Fobs |2k|Fcal||/Shkl|Fobs| where Fobs and Fcal are observed and calculated structure factors, respectively.
bFor Rfree the sum is extended over a subset of reflections (5%) excluded from all stages of refinement.
doi:10.1371/journal.pone.0115082.t002
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1PK9 [10] with bound 2-fluoroadenosine (1.9 Å resolution). Phosphate and
protonated Asp 204 were retained during the calculation. Compound 1 in its
neutral form was subjected to the MacroModel 9.5.212 [30] minimization using
OPLS 2005 (Optimized Potentials for Liquid Simulations) force field with water
solvation treatment and a convergence threshold gradient of 0.01 [31]. Ligand
diameter midpoint was set to a box of 66666 Å encompassing the active site for
receptor grid generation. No ligand constraints were set.
Enzymatic Glycosylation
Enzymatic glycosylations were conducted under the following general conditions.
Compound 1 (4.2 mmol) and deoxynucleoside donor (12.5 mmol) were dissolved
in 0.1 M phosphate buffer adjusted to pH 7.5 with 1 M HCl or 0.5 M 2-[N-
morpholino]ethanesulfonic acid buffer adjusted to pH 8.0 with 10 M NaOH and
the transglycosylase was added to a final reaction volume of 10 mL. Reactions
were incubated overnight at 45 C̊. For incubations with L. helveticus PDT, 40 mg
enzyme were added with dGuo as donor, with L. fermentum and L. leichmannii
NDTs, 40 mg enzyme were added with dCyd as donor. For glycosylation with
thymidine phosphorylase (E. coli)/nucleoside phosphorylase, 0.846 IU phos-
phorylase and 2.536 unit PNP were incubated overnight with 25.5 mmol 1 and
dThyd in 10 mL phosphate buffer (pH 8.0) at 41 C̊.
HPLC Analysis and Isolation of Enzymatic Glycosylation Products
Incubations were filtered, lyophilized, redissolved in ,2 mL H2O and the
products separated by HPLC on an Eclipse XDB C18 column (10064.6 mm)
eluted at 1 mL/min, with a gradient from 5% methanol in 1 mM phosphate
buffer (pH 8.0) to 12% methanol in 1 mM phosphate buffer over 20 min. The
mixture from the thymidine phosphorylase/nucleoside phosphorylase incubation
was filtered, reduced ,50% in volume by lyophilization and then separated by
HPLC as described above. Products were collected at 12, 16, 18 and 22 min (S1
Figure). For reference, authentic 3 eluted at 5.4 min in this system.
12 Min fraction
UV-vis (H2O): lmax (e) 218 (22342), 263 (11056) nm. Exact mass (as the K
+
adduct), m/z calc for C12H13N5O4K
+ 330.0599, found 330.0599. 1H NMR
(500 MHz, DMSO-d6) was identical to 8,9-dihydro-9-oxo-7-(b-D-2-deoxyribo-
furanosyl)-imidazo[2,1-b]purine from chemical glycosylation. (Complete NMR
data are given in S1 Materials and S2 and S3 Figures).
16 Min fraction
UV-vis (H2O): lmax (e) 217 (20867), 263 (9066) nm. Exact mass, m/z calc
292.1040, found 292.1039; (as K+ adduct) calc for C12H13N5O4K
+ 330.0599, found
330.0599. 1H NMR (500 MHz, DMSO-d6) was identical to 8,9-dihydro-9-oxo-1-
(b-D-2-deoxyribofuranosyl)-imidazo[2,1-b]purine from chemical glycosylation.
(Complete NMR data are given in S1 Materials and S4 and S5 Figures).
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18 Min fraction
UV-vis (H2O): lmax (e) 226 (15863), 284 (5318) nm. Exact mass (K
+ adduct), m/
z calc for C12H13N5O4K
+ 330.0599, found 330.0598. (Complete NMR data are
given in S1 Materials and S6 and S7 Figures).
22 Min fraction
UV-vis (H2O): lmax 228, 306 nm. Positive ESI-MS: m/z 330 [M+K]+, 292
[M+H]+, 176 [M+H–deoxyribose]+. (1H NMR data are given in S1 Materials and
S8 Figure).
Results
Crystal Structure and Modeling of the L. helveticus PDT-1 Complex
The initial Fo-Fc electron density map revealed significant electron density for 1 in
the active site of PDT at a contour level of 3 s. However the density did not
uniquely define the orientation of 1, indicating the possibility of multiple
conformations. Examination of the electron density suggests that the substrate
binds in at least four different, overlapping orientations. In the first orientation
(Fig. 2A), the base is anchored in the active site by four hydrogen bonding
interactions. N7 forms a hydrogen bond with carboxyl oxygen OD1 or OD2 of
Asp75, at an N–O bond distance of 2.6 Å or 2.9 Å, respectively. Another hydrogen
bond can link N1 and a C-terminal oxygen atom of Tyr167# from an adjacent
monomer (2.3 Å), while N8 is hydrogen bonded to a water molecule at the active
site. The aromatic ring of the base is also stabilized by a p-stacking herringbone
interaction with Phe45. The second conformation (Fig. 2B) suggests a binding
mode in which the base is rotated by approximately 2120˚ around an axis
perpendicular to the plane of the imidazopurine. In this conformation N7 and N8
form hydrogen bonds with the C terminal carboxylate oxygen atoms of Tyr167#
from the adjacent monomer, each with a bond distance of 2.7 Å. N3 is hydrogen
bonded to Asp75 with a bond distance of 2.5 Å; N1 and O9 participate in two
hydrogen bonds with the active site water molecules. In the third conformation
(Fig. 2C), O9 is hydrogen-bonded to the carboxylate of Asp75 at a distance of
2.5 Å. N1 is within hydrogen bonding distance (2.9 Å) of Asp75 OD1, and N1
and N3 are hydrogen bonded to active site water molecules. In the fourth binding
mode (Fig. 2D), N8 forms a hydrogen bond with OD1 of Asp75 at a distance of
2.4 Å. N3 makes a hydrogen bond with a distance of 2.7 Å to the C-terminal
carboxylate of Tyr167# from the adjacent monomer and N7 forms a hydrogen
bond with Glu101 via a water molecule. The p-stacking herringbone interaction
with Phe45 is conserved in all four orientations. As discussed below, such p-
stacking of an equivalent Phe with bound purines or purine analogs is preserved
in NDT and PNP structures.
Refinements of the models revealed that none of the orientations individually
accounts for the total electron density; a combination of the four orientations is
required to fit the complete electron density (Fig. 2E). The occupancy and B
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values of the ligand were refined in each conformation. The B values were lower
for the model in which all four of the conformations were included, compared to
models where each conformation had a full occupancy; however, the level of
resolution was not sufficient to determine which conformations were predomi-
nant, since all four were weighted equally in the model. Hence product profiles
from enzymic glycosylations need to be examined in order to determine which of
these configurations resulted in product formation, and their relative efficiency.
Modeling of 1 Complexed with L. leichmannii NDT and E. coli PNP
The model of 1 in the active site of L. leichmannii NDT yields two energetically
favorable orientations (Fig. 3A, B). As in the case of the published structures with
5-Me-dyUrd and 39-deoxyadenosine complexed at the active site [9], the
molecular plane of the base is positioned by a p-stacking interaction with Phe13,
which plays the same role as Phe45 in L. helveticus PDT and situates 1 virtually
coplanar with 5-Me-dyUrd in the published structure. While in the case of 5-Me-
dyUrd and 39-deoxyadenosine active site residues Gln46 and Asp 72 are
responsible for substrate binding in the plane of the base, only Gln46 anchors 1. In
the lowest energy orientation (Fig. 3A), H8 of 1 is hydrogen bonded to the
carbonyl oxygen of Gln46. In this orientation, 1 is positioned to accept the
deoxyribose at N7. A second low-energy orientation, related by a 60o rotation in
the molecular plane and displacement by ,21.5 Å along the molecular x-axis of
the base (Fig. 3B), positions N1 to be deoxyribosylated. In this orientation, the
base is anchored by hydrogen bonds between an amido hydrogen of Gln46 and
N7 of 1 and between the carbonyl oxygen of Gln46 and NH8.
In E. coli PNP, the plane of 1 is positioned by a p-stacking interaction with
Phe159, in the same manner as for purines in the PDT and NDT structures [10].
The active site residue responsible for positioning the molecular plane of the base
with respect to rotation about the perpendicular axis is Asp204, as is the case for
other purine derivatives (Fig. 3C, D). In the lowest energy configuration, the
carboxy group of Asp204 is hydrogen bonded to N8H and O9 of 1, positioning N7
as acceptor of the deoxyribosyl group (Fig. 3C). In a second less energetically
favorable orientation, the base is rotated 290o in the molecular plane, so that the
carboxy group of Asp204 now makes a single hydrogen bond to N7, and N1 is
positioned to accept the deoxyribosyl group (Fig. 3D).
Enzymatic Glycosylations
We investigated glycosylation of 1 by purified Type I (PDT) trans N-
deoxyribosyltransferase from L. helveticus, the Type II transferases (NDT) from L.
Fig. 2. The active site of the L. helveticus PDT-1 complex, in the first (A), second (B), third (C) and fourth (D) conformations. The important
surrounding residues are shown in stick representation. The protein C atoms are colored in green, N in blue and O in red. The ligand C atoms are colored
yellow, N in blue and O in red. Graphics were generated from the crystal structures with PyMOL [32]. (E) The Fo-Fc density for ethenoguanine in the active
site of PDT contoured at 2.5 s. The ligand, shown in ball and stick representation, is colored green, yellow, red and blue for the conformations respectively.
doi:10.1371/journal.pone.0115082.g002
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leichmannii (structurally similar to the transferase from L. helveticus [8]) and from
L. fermentum, and by commercially available E. coli PNP. Glycosylations with the
trans N-deoxyribosyltransferase enzymes were performed at pH 7.5 and 8.0 based
on the reported steep pH-dependent activity of purified L. leichmannii [33; J. Biol.
Chem. 1963, 238, 702], while the glycosylation with E. coli PNP was run under
optimal conditions according to the published procedure [14]. The Lactobacillus
trans N-deoxyribosyltransferase enzymes and E. coli PNP generated 2 major
products with retention times of ,12 and 16 min, having a major long-
wavelength UV absorbance band at 260 nm as expected for the angularly-fused
imidazo[2,1-b]purine chromophore. Two minor products with retention times of
18 and 22 min, representing no more than 4% of the substrate, were characterized
by a broad, long wavelength UV band near 300 nm in the electronic spectra,
characteristic of the linear etheno ring fusion of the imidazo[1,2-a]purine
framework. As described below, the major products eluting at 12 and 16 min have
been established as isomeric deoxynucleosides of 1, while the minor products
Fig. 3. Active site model of L. leichmannii NDT-1 complex (A, B) and E. coli PNP-1 complex (C, D)
showing the two most energetically favorable orientations in each case. CPK colors are used in the
models. Hydrogen bonds are shown in green.
doi:10.1371/journal.pone.0115082.g003
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eluting at 18 and 22 min originated, as expected, from glycosylation of 2 (Fig. 4),
present at a level of ,4% in the substrate. The mass spectra of all products
isolated from the enzymatic glycosylations correspond to addition of a
deoxyribosyl moiety to a dihydro oximidazopurine framework. In 1H NMR
spectra of imidazo[2,1-b]purines, the chemical shifts of the protons of the 5-
membered fused (etheno) ring are strongly dependent on the solvent environment
[34] and thus do not provide definitive structural identification. As a
consequence, we confirmed the molecular structures of the enzymatic ribosylation
products eluting at 12, 16 and 18 min by heteronuclear multiple bond shift
correlation (HMBC) and nuclear Overhauser effect spectroscopy (NOESY) NMR.
A sufficient quantity of the peak eluting at 22 min could not be collected for
complete characterization by 2-dimensional NMR spectrometry and identification
is therefore tentative. Expanded regions of the HMBC and NOESY spectra critical
to structural determination are discussed in the text; complete NMR spectra are
presented in S6 and S7 Figures.
The expansion of the HMBC spectrum of the product eluting at 12 min
(Fig. 5A) shows coupling between H19 and C7a and between H19 and C6,
consistent with sugar substitution at N7, while the absence of coupling between
Fig. 4. Structure and numbering conventions of the glycosylated oxoimidazopurine derivatives.
doi:10.1371/journal.pone.0115082.g004
Glycosylation of Ethenoguanines at Non-Natural Sites
PLOS ONE | DOI:10.1371/journal.pone.0115082 December 18, 2014 12 / 25
H19 and C3a, between H19, C9a or C2 or between H2 and C19 is inconsistent with
ribosylation at N1 or N3. N7 ribosylation is further supported by the NOESY
spectrum (Fig. 5B), where a cross peak between H19 and H6 is observed and no
NOESY interactions are detected between H2 and any of the deoxyribose protons.
In the HMBC spectrum of the nucleoside eluting at 16 min (Fig. 6A), ribosylation
at N1 is established by H19/C2, H2/C19 and H19/C9a coupling and the absence of
H19/C3a coupling. (Full HMBC and NOESY spectra are presented as S2 and S3
Figures, respectively.) A NOESY cross peak between H19 and H2 (Fig. 6B) is the
only NOESY interaction between H19 and the base, consistent with N1
ribosylation assigned on the basis of the HMBC spectrum. (Full HMBC and
NOESY spectra are presented as S4 and S5 Figures, respectively.)
As discussed above, the UV absorbance band at 290 nm indicates that the base
moiety of the minor enzymatic products eluting at 18 and 22 min is the linear
Fig. 5. Expansions of the HMBC (A) and NOESY (B) NMR spectra (DMSO-d6) of the 12 min-eluting
product of enzymatic ribosylation of 1, spanning the region of H19-etheno interactions. Proton signals
are identified on the marginal spectral traces. In the HMBC spectrum, unsuppressed one-bond C-H couplings
are indicated by brackets.
doi:10.1371/journal.pone.0115082.g005
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tricyclic 5,9-dihydro-9-oxoimidazo[1,2-a]purine framework. The 1H NMR,
HMBC and NOESY spectra of the product eluting at 18 min were identical to
those of an authentic sample of 5,9-dihydro-9-oxo-3-(b-D-2-deoxyribofurano-
syl)-imidazo[1,2-a]purine, confirming the site of ribosylation at N3. In the
HMBC spectrum (Fig. 7A), H19/C3a and H19/C2 cross-peaks require that the
sugar be attached at N3 and consistent with this observation, the only NOESY
interaction observed between the base and sugar is an H19,H2 cross-peak
(Fig. 7B). (Full HMBC and NOESY spectra are presented as S6 and S7 Figures,
respectively.)
Although it was not possible to acquire 2-dimensional NMR data on the
22 min-eluting sample, the structure 5,9-dihydro-9-oxo-1-(b-D-2-deoxyribofur-
anosyl)-imidazo[1,2-a]purine is assigned based on a report [14] of this isomer as
a minor glycosylation product of 2 by a partially purified mixture of NDT- and
Fig. 6. Expansions of the HMBC (A) and NOESY (B) NMR spectra (DMSO-d6) of the 16 min-eluting
product of enzymatic ribosylation of 1, spanning the region of H19-etheno interactions. Proton signals
are identified on the marginal spectral traces. In the HMBC spectrum, unsuppressed one-bond C-H couplings
are indicated by brackets.
doi:10.1371/journal.pone.0115082.g006
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PDT-containing extracts of L. helveticus. In this report [14], the structure was
unequivocally established by a nuclear Overhauser effect (NOE) difference
spectrum that showed the expected H19/H2 interaction. Unfortunately, the 1H
NMR trace was presented without tabulated proton chemical shifts and a
definitive comparison of 1H NMR shifts and coupling constants is not possible.
Thus, our structural assignment with regard to regiochemistry of glycosylation
must be regarded as tentative, based on the approximate coincidence of the
proton signals (S8 Figure).
Fig. 7. HMBC (A) and NOESY (B) NMR spectra (D2O) of 18 minute-eluting product of enzymatic
glycosylation spanning the region of H19-etheno interactions. Proton signals are identified on marginal
traces. In the HMBC spectrum, unsuppressed 1-bond C-H couplings are identified by brackets.
doi:10.1371/journal.pone.0115082.g007
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The Type II DRTs from L. fermentum and L. leichmannii glycosylated 1 with
high efficiency. While overall efficiency of the glycosylation of 1 was independent
of pH, the product profiles at higher pH show an increase in deoxyribosylation at
N1 at the expense of the N7 isomer. Transribosylation by L. helveticus PDT was
less efficient overall than transribosylation by the Type II transferases, and slightly
more efficient at pH 7.5 than pH 8. The effect of pH on the product profile was
reversed, with the N7 deoxyribosylated product increasing at the expense of the
deoxyribosylation at N1. The three DRTs generated the products eluting at 18 and
22 min efficiently with high selectivity for the product eluting at 18 min regardless
of pH. Although E. coli PNP was nearly an order of magnitude less efficient than
the DRT enzymes at generating the products from 1, all of the enzymes
glycosylated 2 efficiently. Table 3 summarizes extent of conversion and product
profile of 1 and Table 4 summarizes extent of conversion and product profile of 2.
Chemical Glycosylation
O9-Benzyl-protected 8,9-dihydro-9-oxoimidazo[2,1-b]purine was glycosylated
and deprotected by standard methods [19], to examine the steric accessibility of
N3 (N9 in the Gua framework) to chemical deoxyribosylation in solution, which
should impose less rigorous steric constraints than the active site of the enzyme.
The glycosylation reaction yielded only two nucleoside products, which were
identical by 1H NMR and NOESY spectra to the N1 and N7 deoxyribosides
generated enzymatically. Thus deoxyribosylation at N3 is not favorable even in the




We felt that for completeness as well as for absolute confirmation of the structures
assigned to the enzymatic and chemical glycosylation products of 1, comparison
with the authentic N3 glycosylated isomer obtained by an unambiguous synthetic
Table 3. Glycosylation of 8,9-dihydro-9-oxoimidazo[2,1-b]purine (1).
Enzyme pH Conversion in 17 h Ratio of N1/N7 glycosylation
L. helveticus PDT 8.0 41a 3.3
L. helveticus PDT 7.5 62a 2.9
L. fermentum NDT 8.0 92a 0.28
L. fermentum NDT 7.5 85a 0.81
L. leichmannii NDT 8.0 98a 0.15
L. leichmannii NDT 7.5 93a 0.28




Glycosylation of Ethenoguanines at Non-Natural Sites
PLOS ONE | DOI:10.1371/journal.pone.0115082 December 18, 2014 16 / 25
route would be appropriate. Several syntheses of 3 starting with Guo or dGuo
have been reported. The electronic absorption spectra and one-dimensional 1H
NMR spectra provided in support of the target structure do not offer definitive
means to distinguish between the isomers of ribosylation. The insensitivity of
electronic spectra and the chemical shifts of the deoxyribose protons to the
position of ribosylation on the periphery of the base as well as the cited variability
of etheno proton chemical shifts [34] require additional characterization of the
target compound by 2-dimensional NMR experiments. We employed an
unambiguous synthetic route to 3 based on cycloaddition of bromoacetaldehyde
to O6-protected dGuo followed by deprotection [20, 35]. Consistent with the cited
variability of etheno proton chemical shifts [35], the chemical shifts of etheno
proton signals H5 and H6 of the N3-glycosylated product and the products of the
two reported syntheses [20, 35] all differ, notwithstanding the fact that the 1H
NMR spectra were recorded in the same solvent (DMSO-d6). A nuclear
Overhauser effect has been reported between H19 and H5 for O9-protected O9-
benzyl-8,9-dihydro-9-oxo-3-(b-D-ribofuranosyl)-imidazo[2,1-b]purine [34].
However, the equivalent experiment has not been reported for the deoxy analog
or the target deoxynucleoside, and consequently we recorded the NOESY
spectrum of our 8,9-dihydro-9-oxo-3-(2-deoxy-b-D-ribofuranosyl)-imidazo[2,1-
b]purine. The expected H19,H5 interaction was observed (Fig. 8) but interest-
ingly, an H19, H2 NOESY interaction was not detected. The full NOESY spectrum
is given in S9 Figure.
In the report of the synthesis of the O6-protected nucleoside, information was
not provided regarding the presence or absence of a nuclear Overhauser effect
between H19 and H2 in the structurally related O9-benzyl nucleoside. The absence
of this interaction could be explained by hindered rotation around the glycosidic
bond; nevertheless, the synthetic N3-ribosyl derivative is clearly distinct from the
products of enzymatic and chemical glycosylation of the imidazo[2,1-b]purine
system. Moreover, the HPLC retention time obtained under conditions identical
to those of the work-up of the enzymatic glycosylations was significantly shorter
Table 4. Glycosylation of 5,9-dihydro-9-oxoimidazo[1,2-a]purine (2).
Enzyme pH Conversion in 17 h Ratio of N3/N1 glycosylation
L. helveticus PDT 8.0 7.5a 16.9
L. helveticus PDT 7.5 1.8a 15.6
L. fermentum NDT 8.0 2.6a 16.6
L. fermentum NDT 7.5 3.5a 14.6
L. leichmannii NDT 8.0 4.4a 13.6
L. leichmannii NDT 7.5 4.5a 12.6
E. coli PNP 8.0 4.2b,c 19.0
anmole/mg protein.
bnmole/unit protein.
cestimate based on complete glycosylation of substrate.
doi:10.1371/journal.pone.0115082.t004
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(5.4 min) than the retention times of the isomeric deoxyribosylated derivatives
obtained by enzymatic or chemical synthesis.
Discussion
NDT from L. leichmannii [11] deoxyribosylates adenine bearing the bulky C8
substituents Br, Cl or CF3, at both N3 and N9 (referred to the adenine
framework). Crude L. helveticus extracts have been reported to deoxyribosylate
guanine having a 5- or 6-membered ring fused on the Watson-Crick pairing edge
[14] at both N7 and N9 (referred to the guanine framework) while E. coli PNP
similarly yields mixtures of products with purines bearing bulky N2 substituents
[12] as well as with certain base analogs [36, 37]. The deoxyribosyl transfer
reaction proceeds via a ping-pong–bi-bi mechanism [38], illustrated in Fig. 9 for
the L. helveticus enzyme. The deoxyribose at the active site of L. helveticus PDT is
anchored by hydrogen bonding with Ser14, Tyr17, and Asp95, by a covalent a
linkage of oxygen atom OE2 of Glu101 to deoxyribose C19 and by hydrogen
bonding with Asn128# from a neighboring unit [8]. An SN2 displacement of
Glu101 yields the b-anomer of the glycosylated acceptor base thus retaining the b-
anomeric configuration of the deoxynucleoside [36]. The natural base acceptor
Ade is held in place by hydrogen bonds with Tyr167# (from a neighboring unit)
and Asp75 and is further stabilized in the active site by p-stacking with Phe45 [9].
Binding of 1 in Multiple Conformations
Our crystal structure at 2.1 Å resolution indicates that 1 binds in four distinct,
overlapping conformations in the PDT active site. In all orientations, the planar
Fig. 8. NOESY NMR spectrum (DMSO-d6) of 3 spanning the region of H19-etheno interactions. Protons
are identified on the marginal traces.
doi:10.1371/journal.pone.0115082.g008
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purine base is stabilized by p-stacking with Phe45 as observed in the case of L.
helveticus PDT bound to dAdo and other purine derivatives [8]. Thus in our
structure, the purine remains in the same plane with orientations related to each
other by rotation about an axis perpendicular to the plane of the ring. Binding in
conformations related by rotation around the normal to the purine plane
indicates that there is sufficient space in the active site to accommodate the larger
tricyclic, modified base, although the PDT had been thought to be more selective
than the NDT with respect to acceptor molecules.
In the first orientation (Fig. 1A) the tricyclic skeleton is positioned with N8 in
the vicinity of the ribose binding site at Glu101. However, N8 is not anticipated to
be strongly nucleophilic, and a corresponding glycosylation product was not
identified. In the second conformation (Fig. 1B), the base is rotated by
approximately 2120˚but does not offer any nucleophilic sites favorable for attack
and hence is also predicted to be unproductive. Further rotation by 2120˚ yields
the third orientation (Fig. 1C) and places N1 near the sugar binding site, in a
position suitable for glycosylation. In the fourth orientation (Fig. 1D), the base is
bound in the active site in such a way that N7 is positioned near the sugar binding
site and is oriented for nucleophilic attack by the deoxyribosyl moiety. Thus the
crystal structure is compatible with transfer of the deoxyribosyl group from
Glu101 to positions N1 and N7 of the tricyclic base as observed in the product
profile.
The product profile from deoxyribosyl transfer by L. helveticus PDT to 1 shows
a marked preference for addition at N1 relative to N7 (Table 3), which appears to
be in line with the somewhat more extensive H-binding network in orientation
2C. In contrast, glycosylation of 1 by the partially purified protein isolated from L.
helveticus was reported to attach the deoxyribose at N1 and N3 (corresponding to
N7 and N9, respectively, of the guanine skeleton) in equal amounts at pH 6 and
with a marked preference for N3 at pH 8 [14]. The published structural
assignments [14] appear to be based on the assumption that N1 and N3 would be
the target sites for deoxyribosylation, since no spectroscopic confirmation of the
Fig. 9. Pathway of deoxyribosyl transfer.
doi:10.1371/journal.pone.0115082.g009
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structures was presented. Our investigation suggests that the assignment of the N3
glycosylation product be revised. For purified L. helveticus PDT, neither the
efficiency nor regioselectivity of the transfer was as strongly pH-dependent as
reported for the partially purified enzyme mixture, with efficiency being slightly
higher, rather than lower at lower pH.
Substrate Binding in L. leichmannii NDT and E. coli PNP
In the modeled L. leichmannii NDT [9], the planar skeleton of 1 is stabilized in the
active site by p-stacking with Phe13 in a fashion analogous to the stacking
interaction observed for the oxoimidazopurine with Phe45 in L. helveticus PDT.
Modeling indicates that the active site cavity of L. leichmannii NDT has sufficient
space to accommodate the tricyclic skeleton allowing rotation around the normal
to the molecular plane with multiple orientations possible depending on
alternative hydrogen bonding interactions. The most energetically favorable
orientations of 1 were stabilized by hydrogen bonding with Gln46, shown to be
involved in anchoring nucleobase moieties in published crystal structures.
However in contrast to several studies, Asp72 did not participate in anchoring the
substrate in our model. The model predicts that N1 and N7 are optimal sites for
glycosylation in agreement with the observed products, although in the case of the
NDT, differences in hydrogen bonding of the base with the active site residues
must alter the relative ratio of the products. The relative energies of the favored
orientations are in agreement with the observed preference for glycosylation at N7
(Table 3), in contrast to L. helveticus PDT. L. fermentum NDT, like L. helveticus
PDT and L. leichmannii NDT, glycosylated 1 at N1 and N7 with somewhat less
selectivity for N7 than L. leichmannii NDT (Table 3). Structural congruence of L.
fermentum with L. leichmannii NDT based on sequence homology has been
suggested [21] and the similarity of the product profile to that obtained with L.
leichmannii is in accord with this suggestion. However, since a structure of L.
fermentum NDT is not available, no modeling study was done. Both L. leichmannii
and L. fermentum NDTs were slightly more efficient overall than the PDT in
deoxyribosylation, and produced N1 and N7 glycosylated bases with a preference
for N7. Efficiency of the transfer was not significantly pH-dependent, although the
product distribution shifted toward glycosylation at N7 at higher pH.
Glycosylation of multiple positions of the tricyclic base by the DRTs in our study
is in line with the report of mixtures of N3 and N9 deoxyadenosines obtained with
L. leichmanii NDT from C8-substituted Ade depending on the steric demands of
the substituent [11].
The E. coli PNP, like the DRTs, glycosylated 1 at N1 and N7, with the N7
product predominating, although the overall reaction was much less efficient than
for the DRTs. In E. coli PNP, a p-stacking interaction with Phe159 plays a role in
orienting the plane of a purine base in a manner similar to the role of Phe45 in L.
helveticus PDT and Phe13 in L. leichmannii NDT. Position with regard to rotation
about the normal to the purine plane is determined by hydrogen bonding to
Asp204, shown to play a key role in both catalysis and binding of purine to
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residues within the active site [10]. In the model, a single conformation anchored
by two hydrogen bonds with Asp204 presenting N7 for deoxyribosylation is
strongly favored. A second less favorable orientation making one hydrogen bond
with Asp204 would result in deoxyribosylation of N1. The profile of
deoxynucleoside products obtained with 1 bears out this prediction out (Table 3).
Low overall efficiency of the synthesis reaction could result either from a poor fit
to the active site or to sub-optimal orientations of the nucleophilic sites available
for attachment of the deoxyribosyl group.
All DRTs efficiently glycosylated 2 at N3 and at a second site tentatively
identified as N1, with strong selectivity for N3 (N9 of the guanine moiety). This
observation is in accord with the relative efficiency for this substrate reported [14]
using the partially purified L. helveticus enzyme mixture. E. coli PNP displayed the
same pattern of glycosylation of 2 as the DRTs, but in contrast to the low
efficiency of the PNP reaction with 1, efficiency was comparable to that of the
DRTs. Product profiles obtained with 2 are consistent with rotation around the
normal to the molecular plane of the base resulting in positioning of either N1 or
N3 for accepting the deoxyribose.
A common feature of the base-binding pocket of DRTs and E. coli PNP is a Phe
that interacts with purine acceptors by p-stacking that functions to fix the
position of the molecular plane. The orientation of the acceptor base within the
plane is determined by hydrogen bonding interactions with other active-site
residues. In the case of 1, the same active site residues appear to be responsible for
binding natural substrates. For natural substrates, selectivity of ribosylation is
high, whereas in the case of the modified acceptor base, alternative hydrogen
bonding possibilities result in multiple positions with respect to rotation around
the normal to the molecular plane, which in turn, present different targets for
attachment of the deoxyribose. The result is a distribution of products, with
relative yields determined by the proportion of acceptors occupying the rotational
positions.
In the present study neither enzymatic nor chemical glycosylation of 1 yielded
3, as conclusively demonstrated by comparison of HPLC retention times and
NMR data with an authentic sample. In the case of the enzymatic synthesis, the
regiochemistry of glycosylation appears to be determined by the positioning of
nucleophilic sites resulting from specific hydrogen bonding schemes. The
regiochemistry of chemical glycosylation is likely a result of steric hindrance of N3
by location of the nucleophilic target on the peripheral indentation resulting from
the N2,3-fusion of the etheno ring. Supporting this suggestion is the observation
that synthesis of 3 by cycloaddition of bromoacetaldehyde to dGuo required
blocking O6 with a bulky protecting group to prevent exclusive formation of the
1,N2-fusion product. Regioselectivity of deoxyribosylation was correctly predicted
at non-natural sites of the guanine framework both by the crystal structure and
models. This work supports modeling prior to synthetic efforts to accurately
predict products as an aid to determining whether enzymatic synthesis can
achieve target products. The results of this work will also contribute to
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understanding the capabilities of the transglycosylases to accommodate sterically
demanding base analogs.
Accession Codes
Complete structure factor data and final coordinates were deposited in the Protein
Data Bank (www.rcsb.org): PDB ID code 4MEJ.
Notes
For consistency and clarity, the numbering scheme based on the imidazopurine
skeleton is used for the tricyclic bases throughout the text.
Supporting Information
S1 Figure. HPLC trace, monitored at 260 nm, of mixture from ribosylation of 1
by L. fermentum NDT at pH 7.5.
doi:10.1371/journal.pone.0115082.s001 (TIF)
S2 Figure. HMBC spectrum (DMSO-d6) of 12 min peak from enzymic
glycosylation products, identified as 8,9-dihydro-9-oxo-7-(b-D-2-deoxyribo-
furanosyl)-imidazo[2,1-b]purine. 1H and 13C signal assignments are indicated on
marginal traces. Unsuppressed 1-bond C-H couplings are indicated by brackets.
doi:10.1371/journal.pone.0115082.s002 (TIF)
S3 Figure. NOESY spectrum (DMSO-d6) of 12 min peak from enzymic
glycosylation products, identified as 8,9-dihydro-9-oxo-7-(b-D-2-deoxyribo-
furanosyl)-imidazo[2,1-b]purine. 1H signal assignments are indicated on
marginal traces.
doi:10.1371/journal.pone.0115082.s003 (TIF)
S4 Figure. HMBC spectrum (DMSO-d6) of 16 min peak from enzymic
glycosylation products, identified as 8,9-dihydro-9-oxo-1-(b-D-2-deoxyribo-
furanosyl)-imidazo[2,1-b]purine. 1H and 13C signal assignments are indicated on
marginal traces. Unsuppressed 1-bond C-H couplings are indicated by brackets.
doi:10.1371/journal.pone.0115082.s004 (TIF)
S5 Figure. NOESY spectrum (DMSO-d6) of 16 min peak from enzymic
glycosylation products, identified as 8,9-dihydro-9-oxo-1-(b-D-2-deoxyribo-
furanosyl)-imidazo[2,1-b]purine. 1H signal assignments are indicated on
marginal traces.
doi:10.1371/journal.pone.0115082.s005 (TIF)
S6 Figure. HMBC spectrum (DMSO-d6) of 18 min peak from enzymic
glycosylation products, identified as 5,9-dihydro-9-oxo-3-(b-D-2-deoxyribo-
furanosyl)-imidazo[1,2-a]purine. 1H and 13C signal assignments are indicated on
marginal traces. Unsuppressed 1-bond C-H couplings are indicated by brackets.
doi:10.1371/journal.pone.0115082.s006 (TIF)
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S7 Figure. NOESY spectrum (DMSO-d6) of 18 min peak from enzymic
glycosylation products, identified as 5,9-dihydro-9-oxo-3-(b-D-2-deoxyribo-
furanosyl)-imidazo[1,2-a]purine. 1H signal assignments are indicated on
marginal traces.
doi:10.1371/journal.pone.0115082.s007 (TIF)
S8 Figure. 1H NMR spectrum (500 MHz, DMSO-d6) of 22 min peak from
enzymic glycosylations, identified as 5,9-dihydro-9-oxo-1-(b-D-2-deoxyribo-
furanosyl)-imidazo[1,2-a]purine. Peak assignments given on trace are tentative,
based on Ref. (6).
doi:10.1371/journal.pone.0115082.s008 (TIF)
S9 Figure. NOESY spectrum (DMSO-d6) of 8,9-dihydro-9-oxo-3-(b-D-2-
deoxyribofuranosyl)-imidazo[2,1-b]purine. 1H signal assignments are indicated
on marginal traces.
doi:10.1371/journal.pone.0115082.s009 (TIF)




Conceived and designed the experiments: SEE AG LMB. Performed the
experiments: WY DP LG JW RS KJ ZZ PAK. Analyzed the data: SEE AG LMB WY
DP JS ZZ. Contributed reagents/materials/analysis tools: LG RS ZZ PAK. Wrote
the paper: AG LMB SEE.
References
1. Liang S, Li W, Gao T, Zhu X, Yang G, et al. (2010) Enzymatic synthesis of 29 deoxyadenosine and 6-
methylpurine-29-deoxyriboside by Escherichia coli DH5a overexpressing nucleoside phosphorylases
from Escherichia coli BL21. J Biosci Bioeng 110: 165–168.
2. Konstantinova ID, Selezneva OM, Fateev IV, Balashova TA, Kotovskaya SK, et al. (2013) Chemo-
Enzymatic Synthesis and Biological Evaluation of 5,6-Disubstituted Benzimidazole Ribo- and 29-
Deoxyribonucleosides. Synthesis 45: 272–280.
3. Fresco-Taboada A, de la Mata I, Arroyo M, Fernández-Lucas J (2013) New insights on nucleoside 29-
deoxyribosyltransferases: a versatile biocatalyst for one-pot one-step synthesis of nucleoside analogs.
Appl Microbiol Biotechnol 97: 3773–3785.
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